logo-loader
LSE:SVNS OTC:SLVNF

Solvonis Therapeutics PLC

Receive alerts
Market:
LSE
Price
0.09 GBX
Day Change
-
Market Cap:
£7.11 m
52 weeks high
0.33
52 weeks low
0.08

In brief

Solvonis Therapeutics plc is a late clinical-stage biopharmaceutical company developing small-molecule therapeutics for high-burden central nervous system disorders.

Headquartered in London and listed on the Main Market of the London Stock Exchange, Solvonis is advancing a differentiated pipeline of repurposed and proprietary discovery-stage compounds across addiction and psychiatry.

Snapshot

  • Solvonis Therapeutics to target binge eating disorder and gambling addiction with ketamine treatment
  • Solvonis Therapeutics: Clinical-phase innovator flies under the radar. But for how much longer?